Pharma Focus Asia

Croda Commences Construction of New Manufacturing Facility in Pennsylvania, USA

Introduction:

Croda plans for the construction of state-of-the-art facility dedicated to pharmaceutical excipients manufacturing.

Features: 

The upcoming new facility is set to have a crucial impact on advancing future medical discoveries. 

This newly established facility spanning 23,680 square feet, will serve as a manufacturing hub for essential ingredients utilised in the development of drug delivery systems for innovative therapeutic medications, including mRNA vaccines and gene editing therapies.

The facility's scope extends beyond the present, as it will also bolster the production of lipids already employed in therapeutics and vaccines, including the COVID-19 vaccine. 

As an 80-acre multipurpose cGMP site, this facility is expected to generate up to 50 new job opportunities. These roles will span various domains, including engineering, administration, maintenance, operations, and logistics.

Commencement of construction is scheduled for the current year, and the newly manufacturing facility is projected to be operational by the year 2025.   

Specifications:

Name   Croda
Type   New Construction
Year   2025

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?